Accès gratuit
Numéro
Med Sci (Paris)
Volume 28, Numéro 1, Janvier 2012
Page(s) 89 - 95
Section M/S Revues
DOI https://doi.org/10.1051/medsci/2012281022
Publié en ligne 27 janvier 2012
  1. Paget S. The distribution of secondary growths in cancer of the breast. 1889. [1re publication. Lancet 1889 ; 133 : 571–3.] Cancer Metastasis Rev 1989 ; 8 : 98–101. [PubMed]
  2. Welch DR. Do we need to redefine a cancer metastasis and staging definitions ? Breast Dis 2006–2007 ; 26 : 3–12.
  3. Egeblad M, Werb Z. New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer 2002 ; 2 : 161–174. [CrossRef] [PubMed]
  4. Finak G, Laferrière J, Hallett M, Park M. Le microenvironnement tumoral : un nouveau paramètre pronostique dans le cancer du sein. Med Sci (Paris) 2009 ; 25 : 439–441. [CrossRef] [EDP Sciences] [PubMed]
  5. Clark EA, Golub TR, Lander ES, Hynes RO. Genomic analysis of metastasis reveals an essential role for RhoC. Nature 2000 ; 406 : 532–535. [CrossRef] [PubMed]
  6. Friedl P, Wolf K. Tumour-cell invasion and migration: diversity and escape mechanisms. Nat Rev Cancer 2003 ; 3 : 362–374. [CrossRef] [PubMed]
  7. Kaplan RN, Psaila B, Lyden D. Bone marrow cells in the “pre-metastatic niche”: within bone and beyond. Cancer Metastasis Rev 2006 ; 25 : 521–529. [CrossRef] [PubMed]
  8. Mimori K, Fukagawa T, Kosaka Y, et al. Hematogenous metastasis in gastric cancer requires isolated tumor cells and expression of vascular endothelial growth factor receptor-1. Clin Cancer Res 2008 ; 14 : 2609–2616. [CrossRef] [PubMed]
  9. Al-Mehdi AB, Tozawa K, Fisher AB, et al. Intravascular origin of metastasis from the proliferation of endothelium-attached tumor cells: a new model for metastasis. Nat Med 2000 ; 6 : 100–102. [CrossRef] [PubMed]
  10. Aguirre-Ghiso JA. Models, mechanisms and clinical evidence for cancer dormancy. Nat Rev Cancer 2007 ; 7 : 834–846. [CrossRef] [PubMed]
  11. Kim MY, Oskarsson T, Acharyya S, et al. Tumor self-seeding by circulating cancer cells. Cell 2009 ; 139 : 1315–1326. [CrossRef] [PubMed]
  12. Fidler IJ. Metastasis: quantitative analysis of distribution and fate of tumor embolilabeled with 125 I-5-iodo-2’-deoxyuridine. J Natl Cancer Inst 1970 ; 45 : 773–782. [PubMed]
  13. Naumov GN, MacDonald IC, Weinmeister PM, et al. Persistence of solitary mammary carcinoma cells in a secondary site: a possible contributor to dormancy. Cancer Res 2002 ; 62 : 2162–2168. [PubMed]
  14. Nguyen DX, Bos PD, Massagué J. Metastasis: from dissemination to organ-specific colonization. Nat Rev Cancer 2009 ; 9 : 274–284. [CrossRef] [PubMed]
  15. Andre F, Delaloge S. First-generation genomic tests for breast cancer treatment. Lancet Oncol 2010 ; 11 : 6–7. [CrossRef] [PubMed]
  16. Thiery JP, Sleeman JP. Complex networks orchestrate epithelial-mesenchymal transitions. Nat Rev Mol Cell Biol 2006 ; 7 : 131–142. [CrossRef] [PubMed]
  17. Thiery JP. Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer 2002 ; 2 : 442–454. [CrossRef] [PubMed]
  18. Oft M, Akhurst RJ, Balmain A. Metastasis is driven by sequential elevation of H-ras and Smad2 levels. Nat Cell Biol 2002 ; 4 : 487–494. [CrossRef] [PubMed]
  19. Brabletz T, Jung A, Reu S, et al. Variable beta-catenin expression in colorectal cancers indicates tumor progression driven by the tumor environment. Proc Natl Acad Sci USA 2001 ; 98 : 10356–10361. [CrossRef]
  20. Mani SA, Guo W, Liao MJ, et al. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 2008 ; 133 : 704–715. [CrossRef] [PubMed]
  21. Yang J, Mani SA, Donaher JL, et al. Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. Cell 2004 ; 117 : 927–939. [CrossRef] [PubMed]
  22. Fidler IJ, Kripke ML. Metastasis results from preexisting variant cells within a malignant tumor. Science 1977 ; 197 : 893–895. [CrossRef] [PubMed]
  23. Hill RP, Chambers AF, Ling V, Harris JF. Dynamic heterogeneity: rapid generation of metastatic variants in mouse B16 melanoma cells. Science 1984 ; 224 : 998–1001. [CrossRef] [PubMed]
  24. Schmidt-Kittler O, Ragg T, Daskalakis A, et al. From latent disseminated cells to overt metastasis: genetic analysis of systemic breast cancer progression. Proc Natl Acad Sci USA 2003 ; 100 : 7737–7742. [CrossRef]
  25. Steeg PS. Metastasis suppressors alter the signal transduction of cancer cells. Nat Rev Cancer ; 3 : 55–63. [CrossRef] [PubMed]
  26. Ding L, Ellis MJ, Li S, et al. Genome remodelling in a basal-like breast cancer metastasis and xenograft. Nature 2010 ; 464 : 999–1005. [CrossRef] [PubMed]
  27. Yachida S, Jones S, Bozic I, et al. Distant metastasis occurs late during the genetic evolution of pancreatic cancer. Nature 2010 ; 467 : 1114–1117. [CrossRef] [PubMed]
  28. Navin N, Kendall J, Troge J, et al. Tumour evolution inferred by single-cell sequencing. Nature 2011 ; 472 : 90–94. [CrossRef] [PubMed]
  29. Hartwell KA, Muir B, Reinhardt F, et al. The Spemann organizer gene, Goosecoid, promotes tumor metastasis. Proc Natl Acad Sci USA 2006 ; 103 : 18969–18974. [CrossRef]
  30. Karnoub AE, Dash AB, Vo AP, et al. Mesenchymal stem cells within tumour stroma promote breast cancer metastasis. Nature 2007 ; 449 : 557–563. [CrossRef] [PubMed]
  31. Weigelt B, Hu Z, He X, et al. Molecular portraits and 70-gene prognosis signature are preserved throughout the metastatic process of breast cancer. Cancer Res 2005 ; 65 : 9155–9158. [CrossRef] [PubMed]
  32. Bidard FC, Pierga JY, Vincent-Salomon A, Poupon MF. A “class action” against the microenvironment: do cancer cells cooperate in metastasis? Cancer Metastasis Rev 2008 ; 27 : 5–10. [CrossRef] [PubMed]
  33. Kerbel RS, Waghorne C, Korczak B, et al. Clonal dominance of primary tumours by metastatic cells: genetic analysis and biological implications. Cancer Surv 1988 ; 7 : 597–629. [PubMed]
  34. Häfner S, Coulombel L. L’oligarchie contestée des cellules souches cancéreuses. Med Sci (Paris) 2009 ; 25 : 227–228. [CrossRef] [EDP Sciences] [PubMed]
  35. Bidard FC, Ferrand FR, Huguet F, et al. Disseminated and circulating tumor cells in gastrointestinal oncology. Crit Rev Oncol Hematol 2011 ; doi: 10.1016/j.critrevonc.2011.05.008.
  36. Mego M, Mani SA, Cristofanilli M. Molecular mechanisms of metastasis in breast cancer - clinical applications. Nat Rev Clin Oncol 2010 ; 7 : 693–701. [CrossRef] [PubMed]
  37. Coussens LM, Fingleton B, Matrisian LM. Matrix metalloproteinase inhibitors and cancer: trials and tribulations. Science 2002 ; 295 : 2387–2392. [CrossRef] [PubMed]
  38. Le Cabec V, Guiet R, Maridonneau-parini I, van goethem E. La migration des phagocytes : tour d’horizon. Med Sci (Paris) 2011 ; 27 : 1112–1119. [CrossRef] [EDP Sciences] [PubMed]
  39. Quesnel B. Je te tiens, tu me tiens… Dormance tumorale : un équilibre instable ? Med Sci (Paris) 2008 ; 24 : 575–576. [CrossRef] [EDP Sciences] [PubMed]
  40. Puisieux A, Ansieau S. La dissémination précoce de cellules métastatiques : une nouvelle donnée aux conséquences majeures ? Med Sci (Paris) 2009 ; 25 : 28–29. [CrossRef] [EDP Sciences] [PubMed]
  41. Boissan M, Poupon MF, Lacombe ML. NM23 et les gènes suppresseurs de métastases. Med Sci (Paris) 2007 ; 23 : 1115–1123. [CrossRef] [EDP Sciences] [PubMed]

Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.

Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.

Le chargement des statistiques peut être long.